These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8550543)

  • 1. Interaction of bacterial luciferase with 8-substituted flavin mononucleotide derivatives.
    Francisco WA; Abu-Soud HM; Topgi R; Baldwin TO; Raushel FM
    J Biol Chem; 1996 Jan; 271(1):104-10. PubMed ID: 8550543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic destabilization of the hydroperoxy flavin intermediate by site-directed modification of the reactive thiol in bacterial luciferase.
    Abu-Soud HM; Clark AC; Francisco WA; Baldwin TO; Raushel FM
    J Biol Chem; 1993 Apr; 268(11):7699-706. PubMed ID: 8463299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of bacterial luciferase with aldehyde substrates and inhibitors.
    Francisco WA; Abu-Soud HM; Baldwin TO; Raushel FM
    J Biol Chem; 1993 Nov; 268(33):24734-41. PubMed ID: 8227032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of bacterial bioluminescence: 4a,5-dihydroflavin analogs as models for luciferase hydroperoxide intermediates and the effect of substituents at the 8-position of flavin on luciferase kinetics.
    Eckstein JW; Hastings JW; Ghisla S
    Biochemistry; 1993 Jan; 32(2):404-11. PubMed ID: 8422349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stopped-flow kinetic analysis of the bacterial luciferase reaction.
    Abu-Soud H; Mullins LS; Baldwin TO; Raushel FM
    Biochemistry; 1992 Apr; 31(15):3807-13. PubMed ID: 1567836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioluminescence emission of bacterial luciferase with 1-deaza-FMN. Evidence for the noninvolvement of N(1)-protonated flavin species as emitters.
    Kurfürst M; Macheroux P; Ghisla S; Hastings JW
    Eur J Biochem; 1989 May; 181(2):453-7. PubMed ID: 2714296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and stability of the luciferase--flavin intermediate.
    Becvar JE; Tu SC; Hastings JW
    Biochemistry; 1978 May; 17(9):1807-12. PubMed ID: 306832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and catalytic inactivity of the bacterial luciferase neutral flavin radical.
    Kurfürst M; Ghisla S; Presswood R; Hastings JW
    Eur J Biochem; 1982 Apr; 123(2):355-61. PubMed ID: 6978813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on luciferase from Photobacterium phosphoreum. XI. Interaction of 8-substituted FMNH2 with luciferase.
    Watanabe T; Matsui K; Kasai S; Nakamura T
    J Biochem; 1978 Dec; 84(6):1441-6. PubMed ID: 738995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transfers of reduced flavin cofactor and product by bacterial flavin reductase to luciferase.
    Jeffers CE; Tu SC
    Biochemistry; 2001 Feb; 40(6):1749-54. PubMed ID: 11327836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of luminescence decay and flavin binding by the LuxA carboxyl-terminal regions in chimeric bacterial luciferases.
    Valkova N; Szittner R; Meighen EA
    Biochemistry; 1999 Oct; 38(42):13820-8. PubMed ID: 10529227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioluminescence emission from the reaction of luciferase-flavin mononucleotide radical with O2-.
    Kurfürst M; Ghisla S; Hastings JW
    Biochemistry; 1983 Mar; 22(7):1521-5. PubMed ID: 6849864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan 250 on the alpha subunit plays an important role in flavin and aldehyde binding to bacterial luciferase. Effects of W-->Y mutations on catalytic function.
    Li Z; Meighen EA
    Biochemistry; 1995 Nov; 34(46):15084-90. PubMed ID: 7578121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protonation status and control mechanism of flavin-oxygen intermediates in the reaction of bacterial luciferase.
    Tinikul R; Lawan N; Akeratchatapan N; Pimviriyakul P; Chinantuya W; Suadee C; Sucharitakul J; Chenprakhon P; Ballou DP; Entsch B; Chaiyen P
    FEBS J; 2021 May; 288(10):3246-3260. PubMed ID: 33289305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of the bacterial luciferase-flavin mononucleotide complex combining flexible docking with structure-activity data.
    Lin LY; Sulea T; Szittner R; Vassilyev V; Purisima EO; Meighen EA
    Protein Sci; 2001 Aug; 10(8):1563-71. PubMed ID: 11468353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the kinetics and emission spectrum on mutation of the chromophore-binding platform in Vibrio harveyi luciferase.
    Lin LY; Szittner R; Friedman R; Meighen EA
    Biochemistry; 2004 Mar; 43(11):3183-94. PubMed ID: 15023068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio harveyi flavin reductase--luciferase fusion protein mimics a single-component bifunctional monooxygenase.
    Jawanda N; Ahmed K; Tu SC
    Biochemistry; 2008 Jan; 47(1):368-77. PubMed ID: 18067321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the cellular expression of bacterial luciferase.
    Ulitzur S; Reinhertz A; Hastings JW
    Arch Microbiol; 1981 Mar; 129(1):67-71. PubMed ID: 6971634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transfer of reduced flavin mononucleotide from LuxG oxidoreductase to luciferase occurs via free diffusion.
    Tinikul R; Pitsawong W; Sucharitakul J; Nijvipakul S; Ballou DP; Chaiyen P
    Biochemistry; 2013 Oct; 52(39):6834-43. PubMed ID: 24004065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deuterium kinetic isotope effects and the mechanism of the bacterial luciferase reaction.
    Francisco WA; Abu-Soud HM; DelMonte AJ; Singleton DA; Baldwin TO; Raushel FM
    Biochemistry; 1998 Feb; 37(8):2596-606. PubMed ID: 9485410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.